ArticlePloS one2025

Preferences and willingness for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among transfeminine persons in the US, 2022-2023.

Duygu Islek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.